Objective: To compare rates of intracerebral hemorrhage (ICH) in HIV-infected and uninfected individuals in a large clinical care cohort and to assess risk factors associated with ICH.
Methods:We identified incident ICH in HIV-infected and uninfected control cohorts from the Partners Health Care system using ICD-9-CM codes. We constructed Cox proportional hazards models to estimate adjusted hazard ratios for HIV infection and other predictors of ICH.Results: The incidence rate of ICH was 2.29 per 1,000 person-years in HIV-infected individuals compared with 1.23 per 1,000 person-years in uninfected individuals, with an unadjusted incidence rate ratio of 1.85 (95% confidence interval 1.37-2.47, p , 0.001). In a multivariable model, HIV infection was independently associated with a higher hazard of ICH, although its effect diminished with increasing age. Female sex was associated with a lower hazard of ICH in the uninfected cohort but not in the HIV cohort. CD4 count ,200 3 10 6 cells/L and anticoagulant use were predictive of ICH.Conclusions: HIV infection conferred an increased adjusted hazard of ICH, which was more pronounced in young patients and in women. Cardiovascular and cerebrovascular event rates are increased in HIV infection. [1][2][3][4][5][6][7] Several studies pointing to an elevated risk of cerebrovascular disease in HIV-infected individuals have focused on ischemic stroke and excluded intracranial hemorrhage. 5,8,9 Whereas ischemic stroke and cardiovascular disease often coexist and share a similar risk profile and underlying mechanism, the association between HIV and intracerebral hemorrhage (ICH), which has mechanisms distinct from ischemic stroke, is less clear. We examined the association of HIV with the risk of ICH by comparing the incidence of ICH in HIV-infected and uninfected individuals in a large US clinical care cohort. Our primary hypothesis was that the rate of ICH in HIV-infected individuals would be higher than in uninfected individuals. We further controlled for potential confounders and identified predictors of ICH in HIV-infected individuals.METHODS Study design and patient population. We conducted an observational study of an HIV cohort derived from the Partners HealthCare System Research Patient Data Registry (RPDR), a clinical care database of all inpatient and outpatient encounters from Massachusetts General Hospital and Brigham and Women's Hospital. Other vascular outcomes have been studied in this cohort.3,5 HIV-infected individuals were identified from the RPDR using ICD-9-CM codes 042 or V08, previously validated in the cohort. 5 The HIV cohort was matched by age, race, and sex in a 1:10 ratio to HIV-uninfected individuals, who constituted the control cohort. The control cohort was intentionally overpopulated to allow for the possibility of missing data and application of the exclusion criteria. Within the cohorts, individuals who were at least 18 years of age at the beginning of the observation period and who had at least 1 inpatient or 2 outpatient clinical encou...